Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00924560 · ClinicalTrials.gov registry record · Phase 2
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females
A Phase 2 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,361
- Enrollment target
NCT00924560: Completed Phase 2 study, sponsored by Duramed Research.
NCT00924560 is a Phase 2 study that has completed, run by Duramed Research. The registered enrollment target is 1,361 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (923% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00924560, a Phase 2 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,361 participants
- Enrollment target
Study Summary
This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.
Primary Outcome
Bone mineral density was measured by dual energy X-ray absorptiometry (DXA) scan. DXA scans were interpreted centrally by blinded, certified technologists. Percent change from Baseline was calculated as (BMD at Month 12 - BMD at Baseline)/BMD at Baseline \* 100%.
Interventions
- DRUG 91-day Levonorgestrel Oral Contraceptive
- DRUG 28-day Levonorgestrel Oral Contraceptive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,361 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-08 |
| Phase | Phase 2 |
What the finished NCT00924560 record still lists
NCT00924560 is an interventional study that assigns participants to a tested intervention. Its 1,361 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (923% higher).
The record links to 0 conditions, and to 2 interventions - of which 91-day Levonorgestrel Oral Contraceptive is the first listed.
NCT00924560 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00924560 about?
NCT00924560 is a clinical study titled "A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolescent Females". This study is being conducted to compare the effects of a 91-day oral contraceptive (OC) to a 28-day OC regimen on bone mineral density (BMD) in adolescent females.
What is the current status of trial NCT00924560?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,361 participants. The study started on 2009-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00924560?
The interventions under investigation include: 91-day Levonorgestrel Oral Contraceptive (DRUG), 28-day Levonorgestrel Oral Contraceptive (DRUG).
Who is sponsoring clinical trial NCT00924560?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00924560's enrollment target sits among peer trials
1,361 13th of 2000 higher than 1,988 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia